Strategic Industry Position Medbio operates within the highly regulated medical equipment manufacturing industry, serving major OEM clients across orthopedics, cardiovascular, ophthalmology, and biotech sectors, indicating strong market demand for high-quality, compliant manufacturing partnerships.

Rapid Expansion and Capabilities Under Graham Partners ownership since 2018, Medbio has expanded from two to eight facilities and acquired additional capabilities, signaling significant operational growth, which creates opportunities to scale and meet increasing client manufacturing needs.

Innovation and Quality Focus With ISO 13485:2016 certification, FDA registration, and in-house tooling and prototyping, Medbio emphasizes quality and innovation, making it an attractive partner for clients seeking reliable manufacturing solutions for complex and specialized medical devices.

Financial Strength Generating between $25 million and $50 million in revenue, Medbio presents a substantial business profile with growth potential, making it a viable partner for OEMs looking for a stable, proven manufacturing collaborator.

Market Trends and Opportunities The company's focus on biotech, diagnostics, and implantable-grade resins aligns with current industry trends towards personalized medicine and advanced therapeutics, opening avenues for collaborations in emerging medical technologies.